Want to see JP:3154 full AI Analyst Report?
3154 Stock Chart & Stats
¥817.00
-¥8.00(-0.92%)
At close: 4:00 PM EST
¥817.00
-¥8.00(-0.92%)
Day’s Range― - ―
52-Week Range¥759.00 - ¥884.00
Previous CloseN/A
Volume7.50K
Average Volume (3M)23.35K
Market Cap
¥17.35B
Enterprise Value¥26.10K
Total Cash (Recent Filing)¥10.05B
Total Debt (Recent Filing)¥18.39B
Price to Earnings (P/E)18.5
Beta0.55
Next Earnings
Nov 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.54%
Share Statistics
EPS (TTM)42.45
Shares Outstanding22,238,216
10 Day Avg. Volume19,990
30 Day Avg. Volume23,346
Financial Highlights & Ratios
PEG Ratio-0.60
Price to Book (P/B)0.86
Price to Sales (P/S)0.06
P/FCF Ratio-47.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthSustained revenue expansion indicates resilient demand for medical devices and related supplies. Serving hospitals and clinics provides an established healthcare customer base, supporting business continuity over the medium term.
Moderate LeverageLower leverage improves financial flexibility and reduces balance-sheet risk for a distribution business. Growing equity alongside assets provides a stronger capital base to support inventory, working capital and ongoing customer servicing.
Stable Gross MarginStable gross margins suggest the company has retained relatively consistent procurement and resale economics despite operating pressures. This provides a durable foundation for earnings recovery if cost controls and operating efficiency improve.
Bears Say
Compressed ProfitabilityVery thin net margins and declining returns on equity leave limited room to absorb cost inflation or execution errors. Persistently weak profitability could constrain reinvestment, reduce shareholder returns and limit the benefits of revenue growth.
Volatile Cash GenerationUnstable operating cash flow and negative free cash flow weaken confidence in earnings quality and internal funding capacity. Continued working-capital or investment demands could increase reliance on external financing and pressure financial flexibility.
Weak Earnings MomentumDeclining earnings despite expanding revenue indicates that growth is not translating into stronger shareholder economics. Limited pricing power typical of distribution businesses may keep costs from being fully passed through and prolong margin pressure.
Medius Holdings Co., Ltd. News
3154 FAQ
What was Medius Holdings Co., Ltd.’s price range in the past 12 months?
Medius Holdings Co., Ltd. lowest stock price was ¥759.00 and its highest was ¥884.00 in the past 12 months.
What is Medius Holdings Co., Ltd.’s market cap?
Medius Holdings Co., Ltd.’s market cap is ¥17.35B.
When is Medius Holdings Co., Ltd.’s upcoming earnings report date?
Medius Holdings Co., Ltd.’s upcoming earnings report date is Nov 11, 2026 which is in 53 days.
How were Medius Holdings Co., Ltd.’s earnings last quarter?
Medius Holdings Co., Ltd. released its earnings results on Aug 12, 2026. The company reported -¥15.21 earnings per share for the quarter.
Is Medius Holdings Co., Ltd. overvalued?
According to Wall Street analysts Medius Holdings Co., Ltd.’s price is currently Overvalued.
Does Medius Holdings Co., Ltd. pay dividends?
Medius Holdings Co., Ltd. pays a Annually dividend of ¥20 which represents an annual dividend yield of 2.54%. See more information on Medius Holdings Co., Ltd. dividends here
What is Medius Holdings Co., Ltd.’s EPS estimate?
Medius Holdings Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medius Holdings Co., Ltd. have?
Medius Holdings Co., Ltd. has 22,238,216 shares outstanding.
What happened to Medius Holdings Co., Ltd.’s price movement after its last earnings report?
Medius Holdings Co., Ltd. reported an EPS of -¥15.21 in its last earnings report. Following the earnings report the stock price went up 0.763%.
Which hedge fund is a major shareholder of Medius Holdings Co., Ltd.?
Currently, no hedge funds are holding shares in JP:3154
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medius Holdings Co., Ltd.
Medius Holdings Co., Ltd. is a Japanese enterprise deeply embedded in the healthcare sector. The company's operations involve the distribution of a diverse range of medical devices, encompassing fundamental consumables such as syringes and gauze, as well as sophisticated medical systems. In addition to sales, it offers essential repair, after-sales assistance, and maintenance services for this equipment to hospitals and various other medical institutions. Medius Holdings also engages in the provision, through sale and rental, of nursing care and welfare equipment, catering to hospitals, nursing facilities, and private individuals. Moreover, the firm supplies critical emergency response items, including specialized medical instruments for ambulances, automated external defibrillators (AEDs), and other vital emergency provisions that address significant societal needs. Founded in 2009 and based in Tokyo, Japan, the company was formerly known as Kyowa Medical Holdings, Inc. before rebranding to Medius Holdings Co., Ltd. in October 2010.